These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.


BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

111 related articles for article (PubMed ID: 7013165)

  • 1. Substrate-labeled fluorescent immunoassay for phenobarbital.
    Krausz LM; Hitz JB; Buckler RT; Burd JF
    Ther Drug Monit; 1980; 2(3):261-72. PubMed ID: 7013165
    [TBL] [Abstract][Full Text] [Related]  

  • 2. Substrate-labeled fluorescent immunoassay for amikacin in human serum.
    Thompson SG; Burd JF
    Antimicrob Agents Chemother; 1980 Aug; 18(2):264-8. PubMed ID: 7004339
    [TBL] [Abstract][Full Text] [Related]  

  • 3. Substrate-labeled fluorescent immunoassay for measuring dibekacin concentrations in serum and plasma.
    Place JD; Thompson SG
    Antimicrob Agents Chemother; 1983 Aug; 24(2):240-5. PubMed ID: 6357071
    [TBL] [Abstract][Full Text] [Related]  

  • 4. Determination of kanamycin concentration in serum by substrate-labeled fluorescent immunoassay.
    DeCastro AF; Place JD; Lam CT; Patel C
    Antimicrob Agents Chemother; 1986 Jun; 29(6):961-4. PubMed ID: 3524437
    [TBL] [Abstract][Full Text] [Related]  

  • 5. Substrate-labeled fluorescent immunoassay for phenytoin in human serum.
    Wong RC; Burd JF; Carrico RJ; Buckler RT; Thoma J; Boguslaski RC
    Clin Chem; 1979 May; 25(5):686-91. PubMed ID: 108033
    [TBL] [Abstract][Full Text] [Related]  

  • 6. Homogeneous substrate-labeled fluorescent immunoassay for IgG in human serum.
    Ngo TT; Carrico RJ; Boguslaski RC; Burd JF
    J Immunol Methods; 1981; 42(1):93-103. PubMed ID: 7017002
    [TBL] [Abstract][Full Text] [Related]  

  • 7. Homogeneous reactant-labeled fluorescent immunoassay for therapeutic drugs exemplified by gentamicin determination in human serum.
    Burd JF; Wong RC; Feeney JE; Carrico RJ; Boguslaski RC
    Clin Chem; 1977 Aug; 23(8):1402-8. PubMed ID: 326439
    [TBL] [Abstract][Full Text] [Related]  

  • 8. A homogeneous fluorescent immunoassay for human immunoglobulin M.
    Worah D; Yeung KK; Ward FE; Carrico RJ
    Clin Chem; 1981 May; 27(5):673-7. PubMed ID: 7014030
    [TBL] [Abstract][Full Text] [Related]  

  • 9. Homogeneous substrate-labeled fluorescent immunoassay for theophylline in serum.
    Li TM; Benovic JL; Buckler RT; Burd JF
    Clin Chem; 1981 Jan; 27(1):22-6. PubMed ID: 7449119
    [TBL] [Abstract][Full Text] [Related]  

  • 10. Homogeneous substrate-labeled fluorescent immunoassay for human serum albumin.
    Patinkin J; Inbar D; Ben-Gigi C; Derfler S; Klausner Y; Fridlender B
    J Immunoassay; 1983; 4(2):159-74. PubMed ID: 6411772
    [TBL] [Abstract][Full Text] [Related]  

  • 11. Homogeneous substrate-labeled fluorescent immunoassay for disopyramide in human serum: semi- and fully automated procedures.
    Johnson PK; Messenger LJ
    Clin Chem; 1986 Feb; 32(2):378-81. PubMed ID: 3510781
    [TBL] [Abstract][Full Text] [Related]  

  • 12. Capillary electrochemical enzyme immunoassay (CEEI) for phenobarbital in serum.
    Zhang J; Heineman WR; Halsall HB
    J Pharm Biomed Anal; 1999 Feb; 19(1-2):145-52. PubMed ID: 10698576
    [TBL] [Abstract][Full Text] [Related]  

  • 13. Competitive immunoassay of phenobarbital by microchip electrophoresis with laser induced fluorescence detection.
    Huang Y; Zhao S; Shi M; Liu J; Liang H
    Anal Chim Acta; 2011 May; 694(1-2):162-6. PubMed ID: 21565317
    [TBL] [Abstract][Full Text] [Related]  

  • 14. Gentamicin substrate-labeled fluorescent immunoassay containing monoclonal antibody.
    Place JD; Thompson SG; Clements HM; Ott RA; Jensen FC
    Antimicrob Agents Chemother; 1983 Aug; 24(2):246-51. PubMed ID: 6357072
    [TBL] [Abstract][Full Text] [Related]  

  • 15. Simultaneous determination of phenytoin and phenobarbital in serum or plasma by substrate-labeled fluorescent immunoassay.
    Dean KJ; Thompson SG; Burd JF; Buckler RT
    Clin Chem; 1983 Jun; 29(6):1051-6. PubMed ID: 6303626
    [TBL] [Abstract][Full Text] [Related]  

  • 16. Quantitative determination of phenobarbital and phenytoin by dry-phase apoenzyme reactivation immunoassay system (ARIS).
    Croci D; Nespolo A; Tarenghi G
    Ther Drug Monit; 1987 Jun; 9(2):197-202. PubMed ID: 3303469
    [TBL] [Abstract][Full Text] [Related]  

  • 17. Homogeneous substrate-labeled fluorescent immunoassay for carbamazepine.
    Li TM; Miller JE; Ward FE; Burd JF
    Epilepsia; 1982 Aug; 23(4):391-8. PubMed ID: 7047157
    [TBL] [Abstract][Full Text] [Related]  

  • 18. Ligand displacement immunoassay--demonstration of its use for the measurement of serum phenobarbital and phenytoin.
    Hinds JA; Pincombe CF; Smith S; Duffy P
    Clin Chim Acta; 1985 Jul; 149(2-3):105-15. PubMed ID: 3928203
    [TBL] [Abstract][Full Text] [Related]  

  • 19. Rate-nephelometric inhibition immunoassay of phenytoin and phenobarbital.
    Finley PR; Dye JA; Williams RJ; Lichti DA
    Clin Chem; 1981 Mar; 27(3):405-9. PubMed ID: 7471388
    [TBL] [Abstract][Full Text] [Related]  

  • 20. Evaluation of the cloned enzyme donor immunoassay for measurement of phenytoin and phenobarbital in serum.
    van der Weide J; Luiting HJ; Veefkind AH
    Ther Drug Monit; 1993 Aug; 15(4):344-8. PubMed ID: 8236372
    [TBL] [Abstract][Full Text] [Related]  

    [Next]    [New Search]
    of 6.